These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 10979929)
1. Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia. Wang E; Simard M; Ouellet N; Bergeron Y; Beauchamp D; Bergeron MG J Infect Dis; 2000 Oct; 182(4):1255-9. PubMed ID: 10979929 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia. Fonseca-Aten M; Salvatore CM; Mejías A; Ríos AM; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Hardy RD Antimicrob Agents Chemother; 2005 Oct; 49(10):4128-36. PubMed ID: 16189089 [TBL] [Abstract][Full Text] [Related]
5. Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia. Rijneveld AW; Florquin S; Hartung T; Speelman P; van der Poll T J Infect Dis; 2003 Jul; 188(2):282-5. PubMed ID: 12854084 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor antagonist transiently impairs antibacterial defense but not survival in murine pneumococcal pneumonia. Rijneveld AW; Florquin S; Speelman P; Edwards CK; Dinarello CA; van der Poll T Eur Cytokine Netw; 2003; 14(4):242-5. PubMed ID: 14715417 [TBL] [Abstract][Full Text] [Related]
7. Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia. Witzenrath M; Gutbier B; Hocke AC; Schmeck B; Hippenstiel S; Berger K; Mitchell TJ; de los Toyos JR; Rosseau S; Suttorp N; Schütte H Crit Care Med; 2006 Jul; 34(7):1947-54. PubMed ID: 16715037 [TBL] [Abstract][Full Text] [Related]
8. Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. Dallaire F; Ouellet N; Bergeron Y; Turmel V; Gauthier MC; Simard M; Bergeron MG J Infect Dis; 2001 Aug; 184(3):292-300. PubMed ID: 11443554 [TBL] [Abstract][Full Text] [Related]
10. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection. Ríos AM; Mejías A; Chávez-Bueno S; Fonseca-Aten M; Katz K; Hatfield J; Gómez AM; Jafri HS; McCracken GH; Ramilo O; Hardy RD Antimicrob Agents Chemother; 2004 Aug; 48(8):2897-904. PubMed ID: 15273098 [TBL] [Abstract][Full Text] [Related]
11. Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. Rijneveld AW; van den Dobbelsteen GP; Florquin S; Standiford TJ; Speelman P; van Alphen L; van der Poll T J Infect Dis; 2002 Jan; 185(1):123-6. PubMed ID: 11756992 [TBL] [Abstract][Full Text] [Related]
12. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae. Mohler J; Moine P; Azoulay-Dupuis E; Henin D; Fantin B Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae. Kerr AR; Wei XQ; Andrew PW; Mitchell TJ Microb Pathog; 2004 Jun; 36(6):303-10. PubMed ID: 15120156 [TBL] [Abstract][Full Text] [Related]
15. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Yeh CC; Kao SJ; Lin CC; Wang SD; Liu CJ; Kao ST Life Sci; 2007 Apr; 80(20):1821-31. PubMed ID: 17400256 [TBL] [Abstract][Full Text] [Related]
16. Effects of hydroxyethyl starch 130/0.4 on pulmonary capillary leakage and cytokines production and NF-kappaB activation in CLP-induced sepsis in rats. Feng X; Yan W; Liu X; Duan M; Zhang X; Xu J J Surg Res; 2006 Sep; 135(1):129-36. PubMed ID: 16616763 [TBL] [Abstract][Full Text] [Related]
17. Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia. Knapp S; Hareng L; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; Hartung T; van der Poll T J Infect Dis; 2004 Apr; 189(8):1506-15. PubMed ID: 15073689 [TBL] [Abstract][Full Text] [Related]
18. The acute-phase response and serum amyloid A inhibit the inflammatory response to Acinetobacter baumannii Pneumonia. Renckens R; Roelofs JJ; Knapp S; de Vos AF; Florquin S; van der Poll T J Infect Dis; 2006 Jan; 193(2):187-95. PubMed ID: 16362882 [TBL] [Abstract][Full Text] [Related]
19. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin. Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102 [TBL] [Abstract][Full Text] [Related]
20. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. van Zoelen MA; Schouten M; de Vos AF; Florquin S; Meijers JC; Nawroth PP; Bierhaus A; van der Poll T J Immunol; 2009 Apr; 182(7):4349-56. PubMed ID: 19299735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]